Jordi Mata-Fink
Chief Executive Officer at Gate Bioscience, Inc.
Jordi Mata-Fink active positions
Companies | Position | Start | End |
---|---|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2012-12-31 | - |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Chief Executive Officer | 2020-12-31 | - |
Founder | 2020-12-31 | - |
Career history of Jordi Mata-Fink
Former positions of Jordi Mata-Fink
Companies | Position | Start | End |
---|---|---|---|
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Founder | 2016-12-31 | - |
RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
Founder | 2013-12-31 | - |
Training of Jordi Mata-Fink
Stanford University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Founder | 3 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
- Stock Market
- Insiders
- Jordi Mata-Fink
- Experience